留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

高脂血症性胰腺炎研究进展

赵慧佳 吴东 吴文铭

赵慧佳, 吴东, 吴文铭. 高脂血症性胰腺炎研究进展[J]. 协和医学杂志, 2022, 13(4): 637-643. doi: 10.12290/xhyxzz.2021-0760
引用本文: 赵慧佳, 吴东, 吴文铭. 高脂血症性胰腺炎研究进展[J]. 协和医学杂志, 2022, 13(4): 637-643. doi: 10.12290/xhyxzz.2021-0760
ZHAO Huijia, WU Dong, WU Wenming. Research Advances of Hyperlipidemic Pancreatitis[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 637-643. doi: 10.12290/xhyxzz.2021-0760
Citation: ZHAO Huijia, WU Dong, WU Wenming. Research Advances of Hyperlipidemic Pancreatitis[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 637-643. doi: 10.12290/xhyxzz.2021-0760

高脂血症性胰腺炎研究进展

doi: 10.12290/xhyxzz.2021-0760
基金项目: 

国家重点研发计划 2019YFC1315901

北京市自然科学基金 Z190022

详细信息
    通讯作者:

    吴文铭, E-mail: wuwm@pumch.cn

  • 中图分类号: R657.5+1; R576

Research Advances of Hyperlipidemic Pancreatitis

Funds: 

National Key Research and Development Program of China 2019YFC1315901

Natural Science Foundation of Beijing Z190022

More Information
  • 摘要: 高脂血症性胰腺炎(hyperlipidemic pancreatitis,HLP)是急性胰腺炎的重要病因之一,其发病机制主要与游离脂肪酸累积和炎症反应激活有关。HLP临床表现较其他病因的急性胰腺炎症状更重、并发症更多、持续性器官衰竭可能性更高、更易复发,其治疗需采用血浆置换或胰岛素注射等降脂治疗以达到快速降低血清甘油三酯的效果。评估急性胰腺炎患者是否存在高脂血症并作出及时处理,对于HLP患者的预后至关重要。本文将对HLP的流行病学、病因、发病机制、临床表现及治疗进展等进行阐述,以期为HLP的临床诊治提供借鉴和参考。
    作者贡献:赵慧佳负责查阅文献,撰写论文初稿并修订论文;吴东负责提出修改意见;吴文铭负责审校。
    利益冲突:所有作者均声明不存在利益冲突
  • [1] Zhu Y, Pan X, Zeng H, et al. A Study on the Etiology, Severity, and Mortality of 3260 Patients With Acute Pancreatitis According to the Revised Atlanta Classification in Jiangxi, China Over an 8-Year Period[J]. Pancreas, 2017, 46: 504-509. doi:  10.1097/MPA.0000000000000776
    [2] Li X, Ke L, Dong J, et al. Significantly different clinical features between hypertriglyceridemia and biliary acute pancreatitis: a retrospective study of 730 patients from a tertiary center[J]. BMC Gastroenterol, 2018, 18: 89. doi:  10.1186/s12876-018-0821-z
    [3] Eckel RH, Cornier MA. Update on the NCEP ATP-Ⅲ emerging cardiometabolic risk factors[J]. BMC Med, 2014, 12: 115. doi:  10.1186/1741-7015-12-115
    [4] Zheng CB, Zheng ZH, Zheng YP. Therapeutic plasma exchange for hyperlipidemic pancreatitis: Current evidence and unmet needs[J]. World J Clin Cases, 2021, 9: 5794-5803. doi:  10.12998/wjcc.v9.i21.5794
    [5] Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis[J]. J Clin Lipidol, 2019, 13: 947-953. e1. doi:  10.1016/j.jacl.2019.09.005
    [6] Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis[J]. Am J Gastroenterol, 2015, 110: 1497-1503. doi:  10.1038/ajg.2015.261
    [7] Jo SI, Chang JH, Kim TH, et al. Subsets associated with developing acute pancreatitis in patients with severe hypertriglyceridemia and the severity of pancreatitis[J]. Pancreatology, 2019, 19: 795-800. doi:  10.1016/j.pan.2019.08.002
    [8] Li Q, Hou C, Peng Y, et al. Diabetes and Younger Age Are Vital and Independent Risk Factors for Acute Pancreatitis in Patients with Severe Hypertriglyceridemia[J]. Biomed Res Int, 2019, 2019: 2620750.
    [9] Fredrickson DS. An international classification of hyperlipidemias and hyperlipoproteinemias[J]. Ann Intern Med, 1971, 75: 471-472. doi:  10.7326/0003-4819-75-3-471
    [10] Wang L, Xu T, Wang R, et al. Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research[J]. Dig Dis Sci, 2022, 67: 761-772. doi:  10.1007/s10620-021-06928-0
    [11] Paquette M, Hegele RA, Paré G, et al. A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome[J]. J Clin Lipidol, 2018, 12: 506-510. doi:  10.1016/j.jacl.2018.01.011
    [12] Hernandez P, Passi N, Modarressi T, et al. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis[J]. Curr Atheroscler Rep, 2021, 23: 72. doi:  10.1007/s11883-021-00962-z
    [13] Sun X, Zhou X, Dong B, et al. Generation of a gene-corrected isogenic iPSC line (AHQUi001-A-1) from a patient with familial hypertriglyceridemia (FHTG) carrying a hetero-zygous p. C310R (c. 928 T > C) mutation in LPL gene using CRISPR/Cas9[J]. Stem Cell Res, 2021, 52: 102230. doi:  10.1016/j.scr.2021.102230
    [14] Simha V. Management of hypertriglyceridemia[J]. BMJ, 2020, 371: m3109. doi:  10.1007/978-1-59745-533-6_10
    [15] Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment[J]. CMAJ, 2007, 176: 1113-1120. doi:  10.1503/cmaj.060963
    [16] Eichenbaum-Voline S, Olivier M, Jones EL, et al. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia[J]. Arterioscler Thromb Vasc Biol, 2004, 24: 167-174. doi:  10.1161/01.ATV.0000099881.83261.D4
    [17] Chang YT, Chang MC, Su TC, et al. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis[J]. Clin Chem, 2008, 54: 131-138. doi:  10.1373/clinchem.2007.093492
    [18] Ivanova R, Puerta S, Garrido A, et al. Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis[J]. Hepatobiliary Pancreat Dis Int, 2012, 11: 96-101. doi:  10.1016/S1499-3872(11)60131-8
    [19] Cruciat G, Nemeti G, Goidescu I, et al. Hypertriglyceride-mia triggered acute pancreatitis in pregnancy-diagnostic approach, management and follow-up care[J]. Lipids Health Dis, 2020, 19: 2. doi:  10.1186/s12944-019-1180-7
    [20] Yang AL, McNabb-Baltar J. Hypertriglyceridemia and acute pancreatitis[J]. Pancreatology, 2020, 20: 795-800. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1399846
    [21] Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis[J]. Eur J Intern Med, 2014, 25: 689-694. doi:  10.1016/j.ejim.2014.08.008
    [22] Hu X, Gong L, Zhou R, et al. Variations in Gut Microbiome are Associated with Prognosis of Hypertriglyceridemia-Associated Acute Pancreatitis[J]. Biomolecules, 2021, 11: 695. doi:  10.3390/biom11050695
    [23] Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers[J]. Nature, 2013, 500: 541-546. https://www.nature.com/articles/nature12506
    [24] 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华外科杂志, 2021, 59: 578-587. doi:  10.3760/cma.j.cn112139-20210416-00172

    Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association. Guidelines for diagnosis and treatment of acute pancreatitis in China (2021)[J]. Zhonghua Waike Zazhi, 2021, 59: 578-587. doi:  10.3760/cma.j.cn112139-20210416-00172
    [25] Carr RA, Rejowski BJ, Cote GA, et al. Systematic review of hypertriglyceridemia-induced acute pancreatitis: A more virulent etiology?[J]. Pancreatology, 2016, 16: 469-476. doi:  10.1016/j.pan.2016.02.011
    [26] Wang Q, Wang G, Qiu Z, et al. Elevated Serum Triglycerides in the Prognostic Assessment of Acute Pancreatitis: A Systematic Review and Meta-Analysis of Observational Studies[J]. J Clin Gastroenterol, 2017, 51: 586-593. doi:  10.1097/MCG.0000000000000846
    [27] 何文华, 祝荫, 朱勇, 等. 高甘油三酯血症与其他病因所致急性胰腺炎的病情严重程度及预后比较[J]. 中华医学杂志, 2016, 96: 2569-2572. doi:  10.3760/cma.j.issn.0376-2491.2016.32.011

    He WH, Zhu Y, Zhu Y, et al. Comparison of severity and clinical outcomes between hypertriglyceridemic pancreatitis and acute pancreatitis due to other causes[J]. Zhonghua Yixue Zazhi, 2016, 96: 2569-2572. doi:  10.3760/cma.j.issn.0376-2491.2016.32.011
    [28] Pascual I, Sanahuja A, García N, et al. Association of elevated serum triglyceride levels with a more severe course of acute pancreatitis: Cohort analysis of 1457 patients[J]. Pancreatology, 2019, 19: 623-629. doi:  10.1016/j.pan.2019.06.006
    [29] Anderson F, Thomson SR, Clarke DL, et al. Dyslipidaemic pancreatitis clinical assessment and analysis of disease severity and outcomes[J]. Pancreatology, 2009, 9: 252-257. doi:  10.1159/000212091
    [30] Zhang R, Deng L, Jin T, et al. Hypertriglyceridaemia-associated acute pancreatitis: diagnosis and impact on severity[J]. HPB (Oxford), 2019, 21: 1240-1249. doi:  10.1016/j.hpb.2019.01.015
    [31] Zafrir B, Saliba W, Jubran A, et al. Severe Hypertriglyceridemia-Related Pancreatitis: Characteristics and Predictors of Recurrence[J]. Pancreas, 2019, 48: 182-186. doi:  10.1097/MPA.0000000000001235
    [32] Wu BU, Batech M, Dong EY, et al. Influence of Ambulatory Triglyceride Levels on Risk of Recurrence in Patients with Hypertriglyceridemic Pancreatitis[J]. Dig Dis Sci, 2019, 64: 890-897. doi:  10.1007/s10620-018-5226-x
    [33] Vipperla K, Somerville C, Furlan A, et al. Clinical Profile and Natural Course in a Large Cohort of Patients With Hypertriglyceridemia and Pancreatitis[J]. J Clin Gastroenterol, 2017, 51: 77-85.
    [34] 高甘油三酯血症性急性胰腺炎诊治急诊共识专家组. 高甘油三酯血症性急性胰腺炎诊治急诊专家共识[J]. 中华急诊医学杂志, 2021, 30: 937-947. doi:  10.3760/cma.j.issn.1671-0282.2021.08.005
    [35] Garg R, Rustagi T. Management of Hypertriglyceridemia Induced Acute Pancreatitis[J]. Biomed Res Int, 2018, 2018: 4721357. https://www.hindawi.com/journals/bmri/2018/4721357/
    [36] Chen JH, Yeh JH, Lai HW, et al. Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis[J]. World J Gastroenterol, 2004, 10: 2272-2274. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724982/
    [37] Gubensek J, Buturovic-Ponikvar J, Romozi K, et al. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study[J]. PLoS One, 2014, 9: e102748. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105439/
    [38] Berberich AJ, Ziada A, Zou GY, et al. Conservative management in hypertriglyceridemia-associated pancreatitis[J]. J Intern Med, 2019, 286: 644-650. https://www.hindawi.com/journals/bmri/2018/4721357/
    [39] Coskun A, Erkan N, Yakan S, et al. Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin[J]. Prz Gastroenterol, 2015, 10: 18-22. https://www.termedia.pl/Treatment-of-hypertriglyceridemia-induced-acute-pancreatitis-with-insulin,41,23551,0,1.html
    [40] Li J, Chen TR, Gong HL, et al. Intensive insulin therapy in severe acute pancreatitis: a meta-analysis and systematic review[J]. West Indian Med J, 2012, 61: 574-579.
    [41] Jin M, Peng JM, Zhu HD, et al. Continuous intravenous infusion of insulin and heparin vs plasma exchange in hypertriglyceridemia-induced acute pancreatitis[J]. J Dig Dis, 2018, 19: 766-772. https://www.ncbi.nlm.nih.gov/pubmed/4211890
    [42] He WH, Yu M, Zhu Y, et al. Emergent Triglyceride-lowering Therapy With Early High-volume Hemofiltration Against Low-Molecular-Weight Heparin Combined With Insulin in Hypertriglyceridemic Pancreatitis: A Prospective Randomized Controlled Trial[J]. J Clin Gastroenterol, 2016, 50: 772-778.
  • 加载中
计量
  • 文章访问数:  1274
  • HTML全文浏览量:  181
  • PDF下载量:  497
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-11-29
  • 录用日期:  2022-01-18
  • 网络出版日期:  2022-03-05
  • 刊出日期:  2022-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!